Annual D&A
$4.71 M
+$1.02 M+27.72%
December 31, 2023
Summary
- As of February 7, 2025, ACHL annual depreciation & amortization is $4.71 million, with the most recent change of +$1.02 million (+27.72%) on December 31, 2023.
- During the last 3 years, ACHL annual D&A has risen by +$3.94 million (+510.49%).
- ACHL annual D&A is now at all-time high.
Performance
ACHL Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
N/A
September 1, 2024
Summary
- ACHL quarterly depreciation & amortization is not available.
Performance
ACHL Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
N/A
September 1, 2024
Summary
- ACHL TTM depreciation & amortization is not available.
Performance
ACHL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
ACHL Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.7% | - | - |
| 3 y3 years | +510.5% | - | - |
| 5 y5 years | +1460.6% | - | - |
ACHL Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +43.3% | ||||
| 5 y | 5-year | at high | +1460.6% | ||||
| alltime | all time | at high | +1460.6% |
Achilles Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $1.18 M(+6.5%) | $1.18 M(-68.5%) |
| Dec 2023 | $4.71 M(+27.7%) | - | - |
| Mar 2023 | - | $1.11 M(+33.3%) | $3.75 M(+1.5%) |
| Dec 2022 | $3.69 M(+12.2%) | $831.00 K(-6.6%) | $3.69 M(-0.2%) |
| Sep 2022 | - | $890.00 K(-2.8%) | $3.70 M(+1.6%) |
| Jun 2022 | - | $916.00 K(-13.0%) | $3.64 M(+2.4%) |
| Mar 2022 | - | $1.05 M(+25.8%) | $3.55 M(+8.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $3.29 M(+325.9%) | $837.00 K(+0.6%) | $3.29 M(+34.1%) |
| Sep 2021 | - | $832.00 K(+0.2%) | $2.45 M(+51.4%) |
| Jun 2021 | - | $830.00 K(+5.2%) | $1.62 M(+105.2%) |
| Mar 2021 | - | $789.00 K(+713.4%) | $789.00 K(+713.4%) |
| Dec 2020 | $772.00 K(+155.6%) | - | - |
| Mar 2020 | - | $97.00 K | $97.00 K |
| Dec 2019 | $302.00 K | - | - |
FAQ
- What is Achilles Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Achilles Therapeutics?
- What is Achilles Therapeutics annual D&A year-on-year change?
- What is the all time high quarterly D&A for Achilles Therapeutics?
- What is the all time high TTM D&A for Achilles Therapeutics?
What is Achilles Therapeutics annual depreciation & amortization?
The current annual D&A of ACHL is $4.71 M
What is the all time high annual D&A for Achilles Therapeutics?
Achilles Therapeutics all-time high annual depreciation & amortization is $4.71 M
What is Achilles Therapeutics annual D&A year-on-year change?
Over the past year, ACHL annual depreciation & amortization has changed by +$1.02 M (+27.72%)
What is the all time high quarterly D&A for Achilles Therapeutics?
Achilles Therapeutics all-time high quarterly depreciation & amortization is $1.18 M
What is the all time high TTM D&A for Achilles Therapeutics?
Achilles Therapeutics all-time high TTM depreciation & amortization is $3.75 M